# Effects of Modified Duhuo Jisheng Decoction Combined with Arthroscopic Surgery on Bone Metabolism, Oxidative Stress, and Serum TLR4 and TGF-β1 in Patients with Knee Osteoarthritis

Authors: Xiangjing Zeng; Shaoru Lin; Yiliang Li
Journal: Journal of Environmental and Public Health
 (2022)

---

## Abstract

Objective. To analyze the effects of modified Duhuo Jisheng Decoction combined with arthroscopic surgery on bone metabolism, oxidative stress, and serum TLR4 and TGF-β1 in patients with knee osteoarthritis (KOA). Methods. Prospectively select 82 patients with KOA from January 2020 to January 2022 in our hospital and divide them into the control group and observation group according to the random number table method, with 41 patients in each group. The control group was treated with arthroscopic surgery alone and routine anti-infection after operation. The observation group was treated with Duhuo Jisheng Decoction on the basis of the treatment of the control group. The patients in the two groups were treated continuously for 4 weeks. The improvement of patients’ symptoms was evaluated by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Before treatment and 4 weeks after treatment, the scores of traditional Chinese medicine (TCM) symptoms, bone metabolism indicators (cartilage oligomeric matrix protein (COMP), collagen type II carboxy terminal peptide (ctx-II), and matrix metalloproteinase-3 (MMP-3)), oxidative stress indicators (superoxide dismutase (SOD), glutathione peroxidase (GSHPx), malondialdehyde (MDA), nitric oxide (NO)), serum Toll-like receptor 4 (TLR4), and transforming growth factor β (TGF-β) level were compared between the two groups. Results. After treatment, the WOMAC score of the two groups decreased (42.45±10.83) in the observation group and (67.81±14.63) in the control group. The WOMAC score of the observation group was lower than that of the control group (P<0.05). After treatment, the levels of COMP, CTX-II, and MMP-3 in the two groups decreased, and the levels of COMP, CTX-II, and MMP-3 in the observation group were lower than those in the control group (P<0.05). After treatment, the levels of SOD and GSHPx increased, while the levels of MDA and NO decreased in the two groups. The levels of SOD and GSHPx in the observation group were higher than those in the control group, while the levels of MDA and NO were lower than those in the control group (P<0.05). After treatment, the TLR4 level in the observation group was lower than that of the control group, and the level of TGF-β in the observation group was higher than that of the control group (P<0.05). Conclusion. Compared with arthroscopic surgery alone, combined with modified Duhuo Jisheng Decoction can better alleviate the clinical symptoms of patients with KOA, improve their bone metabolism, oxidative stress indicators, and serum TLR4 and TGF-β 1 level, and reduce the inflammatory injury of knee joint.


---

## Body

## 1. Introduction

Knee osteoarthritis (KOA) is also known as knee joint degenerative osteoarthritis; specifically, it refers to the chronic inflammation caused by a variety of factors, the symptoms of which are centered on the degenerative changes of articular cartilage and involve the pathological changes of multiple structures such as bone, synovial membrane, and joint capsule [1, 2]. KOA is a common knee joint disease in clinical practice. In the early stage, the patient with KOA only showed mild soreness or dull pain in the joints. As the disease progressed, the joint movement became unfavorable, pain increased, localized stiffness, joint swelling, etc., which had a great impact on daily life. Relevant data showed that the disability rate of KOA was only less than cardiovascular disease [3, 4]. In recent years, with the increasing aging trend in my country, the incidence of KOA has been increasing, and the clinical treatment of KOA is mostly drug therapy and surgery [5]. Arthroscopic debridement of knee joint is a minimally invasive treatment with short treatment time, which has the characteristics of less trauma and remarkable effect. With the development of minimally invasive technology, the frequency of knee arthroscopy is gradually increased. However, some patients may have sequelae such as nausea, dizziness, and knee swelling after knee arthroscopy [6]. Duhuo Jisheng Decoction is a classic TCM formula for treating KOA. Based on this, this study intends to combine the modified Duhuo Jisheng Decoction with arthroscopic surgery to improve the therapeutic effect of KOA. The results were reported below.


## 2. Materials and Methods

### 2.1. General Information

A total of 82 KOA patients who were admitted to our hospital from January 2020 to January 2022 were prospectively selected and divided into the control group and observation group according to the random number table method, with 41 cases in each group. In the observation group, there were 16 males and 25 females; the age ranged from 48 to 80 years, with an average of (61.44±7.38) years; the course of KOA was 4 to 73 months, with an average of (52.63±13.15) months; Kellgren-Lawrence classification grades II and III were 24 cases and 17 cases, respectively. In the control group, there were 17 males and 24 females; the age ranged from 43 to 75 years, with an average of (62.41±7.36) years; the course of KOA was 5 to 73 months, with an average of (52.54±12.47) months; Kellgren-Lawrence classification grades II and III were 26 cases and 15 cases, respectively. There were no significant differences in gender, age, disease course, and Kellgren-Lawrence classification between the two groups (P>0.05), which were comparable. This study complies with the Declaration of Helsinki.


### 2.2. Diagnostic Criteria

Based on the “Guidelines for the Diagnosis and Treatment of Osteoarthritis (2018 Edition)” formulated by the Joint Surgery Group of the Orthopaedic Branch of the Chinese Medical Association, the diagnostic criteria for KOA were formulated: ① signs include joint pain, swelling, stiffness, deformity, a sense of snapping or friction, limited joint movement, and difficulty in walking or squatting [7]; ② recurrent joint pain within 1 month; ③ knee X-ray examination showed asymmetric joint space narrowing, subchondral bone sclerosis or cystic lesions, and osteophyte formation at the joint edge; and ④ magnetic resonance examination showed the thickness of knee articular cartilage thinning, defect, bone marrow edema, cystic changes, and some joint effusion or popliteal cyst.


### 2.3. Inclusion and Exclusion Criteria

Inclusion criteria were as follows: ① patients who met the diagnostic criteria of KOA had the corresponding symptoms and were confirmed by knee joint X-ray examination after admission; ② age of patients over 18 years old; ③ patients with Kellgren-Lawrence’s classification is grade II or III; ④ patients meeting indications for arthroscopic surgery; ⑤ patients who are not allergic to the drugs used in this study; ⑥ patients who have not received other KOA treatment drugs in the past 1 month; and ⑦ patients and their families understand the research content, know the pros and cons, and have signed the informed consent. Exclusion criteria were as follows: ① combined with rheumatoid arthritis or other types of arthritis; ② patients with contraindications to surgery; ③ combined with bone tumor or other malignant tumor bone metastasis; ④ patients had severe joint space stenosis and required joint replacement; ⑤ patients with bilateral KOA; ⑥ and patients with knee joint skin injury or knee joint local infection.


### 2.4. Methods

Both groups of patients underwent knee arthroscopy. The operation steps were as follows: take the patient in a supine position, perform epidural anesthesia, fix the balloon tourniquet on the thigh root of the affected limb, keep the knee joint flexed at 90°, and keep the affected limb at 90°. In a normal drooping state, inflate the airbag after disinfection and towel laying operation. Select the joint approach of anteromedial and anterolateral knee joint, anterolateral approach for arthroscopy, and anteromedial approach for surgical operations. After the approach, the joints were washed with a large amount of normal saline, and the inspections were carried out in order. Surgical operations include cleaning up floating debris, excision of hyperplastic synovium, trimming of meniscus, grinding of osteophytes, etc., removal of loose bodies, and subsequent grinding of cartilage shedding and bone surface. Players drill microholes on the surface of cartilage and rinse the joint with a large amount of normal saline. After operation, check whether the range of motion of the joints is normal, confirm that there is no abnormal compression and snapping, then suture the wound, and use an elastic bandage for pressure dressing for 48 hours to avoid massive bleeding. After the operation, a drainage tube was set in the affected area for 24 hours, antibiotics were used for 4-5 days, and the quadriceps muscle rehabilitation training was performed after the drainage tube was removed. On this basis, the patients in the observation group were treated with Duhuo Jisheng Decoction orally. The prescriptions were as follows: Duhuo 15 g, Asarum 6 g, Angelica sinensis 10 g, Licorice 10 g, Cinnamon Heart 10 g, Eucommia 10 g, Qinji 10 g, Achyranthes 10 g, Fangfeng 10 g, Shaoyao 10 g, Rehmannia glutinosa 10 g, Chuanxiong 10 g, Mulberry parasitic 10 g, and Poria 10 g. For those with severe pain, add Fuzi 5 g, for those with severe limbs, add Atractylodes 6 g and Papaya 9 g, if the congestion persists, add 9 g of Salvia miltiorrhiza and 12 g of Chickweed, and for those with a longer course of disease, add 9 g of Dilong and a centipede. Add 600 ml of water to decoct, remove the residue, take 300 ml of juice, take one dose a day, warm twice in the morning and evening, and take it continuously for 4 weeks.


### 2.5. Observation Indicators

① The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) was as follows: the WOMAC score was evaluated before treatment and after 4 weeks of treatment. The scale contains three dimensions, namely, pain (5 items), stiffness (2 items), and difficulty in performing daily activities (17 items); with a total of 24 items, each item is 0-9 points, and the higher the total score, the more severe the symptoms. ② In bone metabolism index, 5 ml of fasting venous blood was collected from patients before treatment and after 4 weeks of treatment, 3000 r/min centrifugation for 10 min, and the upper serum was taken and stored at -70°C for testing. The levels of cartilage oligomeric matrix protein (COMP), collagen type II carboxy-terminal peptide (CTX-II), and matrix metalloproteinase-3 (MMP-3) were detected by enzyme-linked immunosorbent assay. The kits were selected from Beijing Rongzhi Haida Biotechnology Co., Ltd. ③ In oxidative stress indicators, before treatment and after 4 weeks of treatment, the synovial fluid of the patient was collected, centrifuged at 2500 r/min for 5 min, and the supernatant was collected by enzyme-linked immunosorbent assay to detect superoxide dismutase (SOD), glutathione peroxidase (GSHPx), malondialdehyde (MDA), and nitric oxide (NO) levels, and the kits were selected from Shanghai Enzyme Link Biopharmaceutical Co., Ltd.; ④ serum Toll-like receptor 4 (TLR4), transforming growth factorβ (TGF-β) levels, and serum samples were taken from patients before treatment and after 4 weeks of treatment (the operation method is the same as ②), the enzyme-linked immunosorbent assay was used to detect TLR4 and TGF-β, and the kit was selected from Nanjing Jinyibai Biotechnology Co., Ltd.


### 2.6. Statistical Processing

The statistical software SPSS22.0 was used to process the data, the count data were expressed as (n, %), and the χ2 test was performed. The measurement data (such as WOMAC score, bone metabolism index, oxidative stress index, and serum TLR4 and TGF-β levels) was expressed as the mean±standarddeviationx¯±s. Graphing was done with GraphPad Prism 8 software.


## 2.1. General Information

A total of 82 KOA patients who were admitted to our hospital from January 2020 to January 2022 were prospectively selected and divided into the control group and observation group according to the random number table method, with 41 cases in each group. In the observation group, there were 16 males and 25 females; the age ranged from 48 to 80 years, with an average of (61.44±7.38) years; the course of KOA was 4 to 73 months, with an average of (52.63±13.15) months; Kellgren-Lawrence classification grades II and III were 24 cases and 17 cases, respectively. In the control group, there were 17 males and 24 females; the age ranged from 43 to 75 years, with an average of (62.41±7.36) years; the course of KOA was 5 to 73 months, with an average of (52.54±12.47) months; Kellgren-Lawrence classification grades II and III were 26 cases and 15 cases, respectively. There were no significant differences in gender, age, disease course, and Kellgren-Lawrence classification between the two groups (P>0.05), which were comparable. This study complies with the Declaration of Helsinki.


## 2.2. Diagnostic Criteria

Based on the “Guidelines for the Diagnosis and Treatment of Osteoarthritis (2018 Edition)” formulated by the Joint Surgery Group of the Orthopaedic Branch of the Chinese Medical Association, the diagnostic criteria for KOA were formulated: ① signs include joint pain, swelling, stiffness, deformity, a sense of snapping or friction, limited joint movement, and difficulty in walking or squatting [7]; ② recurrent joint pain within 1 month; ③ knee X-ray examination showed asymmetric joint space narrowing, subchondral bone sclerosis or cystic lesions, and osteophyte formation at the joint edge; and ④ magnetic resonance examination showed the thickness of knee articular cartilage thinning, defect, bone marrow edema, cystic changes, and some joint effusion or popliteal cyst.


## 2.3. Inclusion and Exclusion Criteria

Inclusion criteria were as follows: ① patients who met the diagnostic criteria of KOA had the corresponding symptoms and were confirmed by knee joint X-ray examination after admission; ② age of patients over 18 years old; ③ patients with Kellgren-Lawrence’s classification is grade II or III; ④ patients meeting indications for arthroscopic surgery; ⑤ patients who are not allergic to the drugs used in this study; ⑥ patients who have not received other KOA treatment drugs in the past 1 month; and ⑦ patients and their families understand the research content, know the pros and cons, and have signed the informed consent. Exclusion criteria were as follows: ① combined with rheumatoid arthritis or other types of arthritis; ② patients with contraindications to surgery; ③ combined with bone tumor or other malignant tumor bone metastasis; ④ patients had severe joint space stenosis and required joint replacement; ⑤ patients with bilateral KOA; ⑥ and patients with knee joint skin injury or knee joint local infection.


## 2.4. Methods

Both groups of patients underwent knee arthroscopy. The operation steps were as follows: take the patient in a supine position, perform epidural anesthesia, fix the balloon tourniquet on the thigh root of the affected limb, keep the knee joint flexed at 90°, and keep the affected limb at 90°. In a normal drooping state, inflate the airbag after disinfection and towel laying operation. Select the joint approach of anteromedial and anterolateral knee joint, anterolateral approach for arthroscopy, and anteromedial approach for surgical operations. After the approach, the joints were washed with a large amount of normal saline, and the inspections were carried out in order. Surgical operations include cleaning up floating debris, excision of hyperplastic synovium, trimming of meniscus, grinding of osteophytes, etc., removal of loose bodies, and subsequent grinding of cartilage shedding and bone surface. Players drill microholes on the surface of cartilage and rinse the joint with a large amount of normal saline. After operation, check whether the range of motion of the joints is normal, confirm that there is no abnormal compression and snapping, then suture the wound, and use an elastic bandage for pressure dressing for 48 hours to avoid massive bleeding. After the operation, a drainage tube was set in the affected area for 24 hours, antibiotics were used for 4-5 days, and the quadriceps muscle rehabilitation training was performed after the drainage tube was removed. On this basis, the patients in the observation group were treated with Duhuo Jisheng Decoction orally. The prescriptions were as follows: Duhuo 15 g, Asarum 6 g, Angelica sinensis 10 g, Licorice 10 g, Cinnamon Heart 10 g, Eucommia 10 g, Qinji 10 g, Achyranthes 10 g, Fangfeng 10 g, Shaoyao 10 g, Rehmannia glutinosa 10 g, Chuanxiong 10 g, Mulberry parasitic 10 g, and Poria 10 g. For those with severe pain, add Fuzi 5 g, for those with severe limbs, add Atractylodes 6 g and Papaya 9 g, if the congestion persists, add 9 g of Salvia miltiorrhiza and 12 g of Chickweed, and for those with a longer course of disease, add 9 g of Dilong and a centipede. Add 600 ml of water to decoct, remove the residue, take 300 ml of juice, take one dose a day, warm twice in the morning and evening, and take it continuously for 4 weeks.


## 2.5. Observation Indicators

① The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) was as follows: the WOMAC score was evaluated before treatment and after 4 weeks of treatment. The scale contains three dimensions, namely, pain (5 items), stiffness (2 items), and difficulty in performing daily activities (17 items); with a total of 24 items, each item is 0-9 points, and the higher the total score, the more severe the symptoms. ② In bone metabolism index, 5 ml of fasting venous blood was collected from patients before treatment and after 4 weeks of treatment, 3000 r/min centrifugation for 10 min, and the upper serum was taken and stored at -70°C for testing. The levels of cartilage oligomeric matrix protein (COMP), collagen type II carboxy-terminal peptide (CTX-II), and matrix metalloproteinase-3 (MMP-3) were detected by enzyme-linked immunosorbent assay. The kits were selected from Beijing Rongzhi Haida Biotechnology Co., Ltd. ③ In oxidative stress indicators, before treatment and after 4 weeks of treatment, the synovial fluid of the patient was collected, centrifuged at 2500 r/min for 5 min, and the supernatant was collected by enzyme-linked immunosorbent assay to detect superoxide dismutase (SOD), glutathione peroxidase (GSHPx), malondialdehyde (MDA), and nitric oxide (NO) levels, and the kits were selected from Shanghai Enzyme Link Biopharmaceutical Co., Ltd.; ④ serum Toll-like receptor 4 (TLR4), transforming growth factorβ (TGF-β) levels, and serum samples were taken from patients before treatment and after 4 weeks of treatment (the operation method is the same as ②), the enzyme-linked immunosorbent assay was used to detect TLR4 and TGF-β, and the kit was selected from Nanjing Jinyibai Biotechnology Co., Ltd.


## 2.6. Statistical Processing

The statistical software SPSS22.0 was used to process the data, the count data were expressed as (n, %), and the χ2 test was performed. The measurement data (such as WOMAC score, bone metabolism index, oxidative stress index, and serum TLR4 and TGF-β levels) was expressed as the mean±standarddeviationx¯±s. Graphing was done with GraphPad Prism 8 software.


## 3. Results

### 3.1. Comparison of WOMAC Scores between the Two Groups

Before treatment, the WOMAC score of the observation group was (106.74±20.14) points, and that of the control group was (108.02±19.45) points. After treatment, the WOMAC scores of both groups decreased, the observation group was (42.45±10.83) points, and the control group was (67.81±14.63) points; the WOMAC score of the observation group was lower than that of the control group, and the difference was statistically significant (t=−8.948, P<0.05), as shown in Figure 1.Figure 1
Comparison of WOMAC scores between the two groups.


### 3.2. Comparison of Bone Metabolism Indexes between the Two Groups

Before treatment, there was no statistical difference in three bone metabolism indexes between the two groups (P>0.05). After treatment, the levels of COMP, CTX-II, and MMP-3 in the two groups were decreased, the levels of COMP, CTX-II, and MMP-3 in the observation group were lower than those in the control group, and the difference was statistically significant (P<0.05), as shown in Table 1.Table 1
Comparison of bone metabolism indexes between the two groupsx¯±s.
GroupTimeCOMP (ng/l)CTX-II (ng/l)MMP-3 (ng/l)Observation group (n=41)Before treatment4.01±0.52560.37±100.283.78±0.40After treatment2.94±0.35430.16±82.452.60±0.30t19.31810.89516.866P<0.001<0.001<0.001Control group (n=41)Before treatment4.03±0.49570.14±108.653.80±0.37After treatment3.32±0.37483.54±90.453.31±0.29t12.3465.54710.063P<0.001<0.001<0.001Before treatment between groupst-0.179-0.423-0.235P0.8580.6730.815After treatment between groupst-4.774-2.793-10.894P<0.0010.007<0.001


### 3.3. Comparison of Oxidative Stress Indicators between the Two Groups

Before treatment, there was no significant difference in the four oxidative stress indicators between the two groups (P>0.05). After treatment, the levels of SOD and GSHPx in the two groups were increased, while the levels of MDA and NO were decreased, the levels of SOD and GSHPx in the observation group were higher than those in the control group, and the levels of MDA and NO were lower than those in the control group, with statistical significance (P<0.05), as shown in Table 2.Table 2
Comparison of oxidative stress indicators between the two groupsx¯±s.
GroupTimeSOD (nU/ml)GSHPx (U/l)MDA (nmol/ml)NO (μmol/l)Observation group (n=41)Before treatment80.14±7.9083.12±6.687.54±1.3024.15±2.70After treatment118.45±10.38116.64±10.453.72±0.6016.34±1.57t-30.193-23.08217.96623.398P<0.001<0.001<0.001<0.001Control group (n=41)Before treatment81.50±7.4284.00±6.487.59±1.2524.20±2.62After treatment99.67±8.45102.45±8.375.12±0.8019.31±1.98t-16.824-17.25315.35513.314P<0.001<0.001<0.001<0.001Before treatment between groupst-0.803-0.606-0.177-0.085P0.4240.5470.8600.932After treatment between groupst8.9846.787-8.963-7.526P<0.001<0.001<0.001<0.001


### 3.4. Comparison of TLR4 and TGF-β Levels between the Two Groups

Before treatment, the levels of TLR4 and TGF-β in the observation group were (18.05±1.20) ng/ml and (20.12±4.34) μg/ml, and those in the control group were (18.07±1.21) ng/ml and (20.07±4.39) μg/ml; after treatment, the levels of TLR4 in both groups decreased, while the levels of TGF-β increased. The levels of TLR4 and TGF-β in the observation group were (10.45±1.32) ng/ml and (28.45±5.36) μg/ml, respectively, and the control group was (14.45±1.40) ng/ml and (24.64±5.07) μg/ml; the level of TLR4 in the observation group was lower than that in the control group, but the level of TGF-β1 was higher than that in the control group, and the differences were statistically significant (t=−13.308, 3.307, P<0.001), as shown in Figure 2.Figure 2
Comparison of TLR4 and TGF-β levels between the two groups.


## 3.1. Comparison of WOMAC Scores between the Two Groups

Before treatment, the WOMAC score of the observation group was (106.74±20.14) points, and that of the control group was (108.02±19.45) points. After treatment, the WOMAC scores of both groups decreased, the observation group was (42.45±10.83) points, and the control group was (67.81±14.63) points; the WOMAC score of the observation group was lower than that of the control group, and the difference was statistically significant (t=−8.948, P<0.05), as shown in Figure 1.Figure 1
Comparison of WOMAC scores between the two groups.


## 3.2. Comparison of Bone Metabolism Indexes between the Two Groups

Before treatment, there was no statistical difference in three bone metabolism indexes between the two groups (P>0.05). After treatment, the levels of COMP, CTX-II, and MMP-3 in the two groups were decreased, the levels of COMP, CTX-II, and MMP-3 in the observation group were lower than those in the control group, and the difference was statistically significant (P<0.05), as shown in Table 1.Table 1
Comparison of bone metabolism indexes between the two groupsx¯±s.
GroupTimeCOMP (ng/l)CTX-II (ng/l)MMP-3 (ng/l)Observation group (n=41)Before treatment4.01±0.52560.37±100.283.78±0.40After treatment2.94±0.35430.16±82.452.60±0.30t19.31810.89516.866P<0.001<0.001<0.001Control group (n=41)Before treatment4.03±0.49570.14±108.653.80±0.37After treatment3.32±0.37483.54±90.453.31±0.29t12.3465.54710.063P<0.001<0.001<0.001Before treatment between groupst-0.179-0.423-0.235P0.8580.6730.815After treatment between groupst-4.774-2.793-10.894P<0.0010.007<0.001


## 3.3. Comparison of Oxidative Stress Indicators between the Two Groups

Before treatment, there was no significant difference in the four oxidative stress indicators between the two groups (P>0.05). After treatment, the levels of SOD and GSHPx in the two groups were increased, while the levels of MDA and NO were decreased, the levels of SOD and GSHPx in the observation group were higher than those in the control group, and the levels of MDA and NO were lower than those in the control group, with statistical significance (P<0.05), as shown in Table 2.Table 2
Comparison of oxidative stress indicators between the two groupsx¯±s.
GroupTimeSOD (nU/ml)GSHPx (U/l)MDA (nmol/ml)NO (μmol/l)Observation group (n=41)Before treatment80.14±7.9083.12±6.687.54±1.3024.15±2.70After treatment118.45±10.38116.64±10.453.72±0.6016.34±1.57t-30.193-23.08217.96623.398P<0.001<0.001<0.001<0.001Control group (n=41)Before treatment81.50±7.4284.00±6.487.59±1.2524.20±2.62After treatment99.67±8.45102.45±8.375.12±0.8019.31±1.98t-16.824-17.25315.35513.314P<0.001<0.001<0.001<0.001Before treatment between groupst-0.803-0.606-0.177-0.085P0.4240.5470.8600.932After treatment between groupst8.9846.787-8.963-7.526P<0.001<0.001<0.001<0.001


## 3.4. Comparison of TLR4 and TGF-β Levels between the Two Groups

Before treatment, the levels of TLR4 and TGF-β in the observation group were (18.05±1.20) ng/ml and (20.12±4.34) μg/ml, and those in the control group were (18.07±1.21) ng/ml and (20.07±4.39) μg/ml; after treatment, the levels of TLR4 in both groups decreased, while the levels of TGF-β increased. The levels of TLR4 and TGF-β in the observation group were (10.45±1.32) ng/ml and (28.45±5.36) μg/ml, respectively, and the control group was (14.45±1.40) ng/ml and (24.64±5.07) μg/ml; the level of TLR4 in the observation group was lower than that in the control group, but the level of TGF-β1 was higher than that in the control group, and the differences were statistically significant (t=−13.308, 3.307, P<0.001), as shown in Figure 2.Figure 2
Comparison of TLR4 and TGF-β levels between the two groups.


## 4. Discussions

KOA is a common orthopedic disease in the elderly, and its incidence is closely related to knee strain and body trauma. Some scholars have found that most patients with KOA are caused by the reduction of endogenous sodium hyaluronate in synovial fluid and cartilage or the imbalance of synthetic degradation [8, 9]. There is currently no targeted radical cure for KOA in clinical treatment. Most of them focus on relieving knee joint degeneration, improving pain, preventing disease progression, and ensuring a high quality of life for patients [10]. In past clinical experience, intra-articular injection of sodium hyaluronate can form a protective film on the knee joint surface to avoid tissue adhesion, thereby improving joint mobility [11]. However, some patients have a high recurrence rate after receiving treatment, and the effect on improving the quality of life is limited. In recent years, with the continuous updating of medical concepts, TCM treatment for KOA patients has been recognized clinically in China on the basis of modern medical treatment [12].Knee arthroscopy is a commonly used minimally invasive cleaning method in orthopaedics. It has obvious effects on improving joint wear and meniscus damage, removing abnormal knee joint debris and proliferative tissue, and improving joint mobility. After knee arthroscopy, most patients can effectively control the development of the disease and avoid the need for knee replacement [13, 14]. In this study, the WOMAC scores of 41 control patients were significantly reduced after arthroscopic surgery, and the bone metabolism indexes and oxidative stress indexes were well improved, indicating that arthroscopic surgery does have a certain therapeutic effect on KOA patients. This is because in the process of arthroscopic surgery, continuous irrigation can effectively remove necrotic tissue, improve the internal environment of the body, and speed up recovery. However, from the analysis of clinical data in recent years, due to the different pathogenic factors and constitutions of patients, the effective rate of surgery has been significantly decreased in some patients. Therefore, selecting certain combined treatment according to the situation of patients after knee arthroscopy can improve the overall treatment effect of KOA [15].There is no separate definition of KOA in traditional Chinese medicine, but it can be attributed to the field of “arthromyodynia.” The theory of TCM believes that KOA is related to the six exogenous pathogens caused by aging and physical insufficiency, lack of righteousness, and deficiency of the body. Dampness and cold are their causes; so, TCM treatment of KOA should focus on nourishing the liver and kidney, dispelling rheumatism, relieving pain, and dredging meridians [16–19]. Duhuo Jisheng Decoction is a TCM decoction made by Sun Simiao, a famous Chinese medical scientist. The results of this study showed that after treatment, the WOMAC score of the observation group was significantly lower than that of the control group, and its bone metabolism indexes and oxidative stress indexes improved more obviously. This shows that the Duhuo Jisheng Decoction combined with arthroscopic surgery can significantly improve the efficiency of symptom recovery and knee joint activity. In addition, by detecting the levels of TLR4 and TGF-β, it was found that the level of TLR4 in the observation group was lower than that of the control group, and the level of TGF-β was higher than that of the control group. TLR4 mainly mediates innate immunity and inflammatory response, and TGF-β can decompose chondrocytes. Proteoglycan produced a reversal effect, which further indicated that the modified application of Duhuo Jijitang could improve cartilage metabolism and internal environment inflammation to some extent. It is speculated that the reason is that Duhuo Jisheng Decoction uses Duhuo as the monarch medicine, which can control the wind and eliminate the pathogens of wind, cold, and dampness between the “lower energizer” and the muscles and bones. Asarum can disperse the wind-cold in the yin meridian and has analgesic effect. Ginseng can invigorate Qi and spleen; Angelica can activate blood and nourish Qi. Combination of various drugs can treat arthralgia caused by deficiency of the liver and kidney and deficiency of Qi and blood. In addition, we also modified the original prescription of Duhuo Jisheng decoction according to different constitutions of patients: for patients with severe pain, add Fuzi 5 g, for those with severe limbs, add Atractylodes 6 g and Papaya 9 g, if the congestion persists, add 9 g of Salvia miltiorrhiza and 12 g of Chickweed, and for those with a longer course of disease, add 9 g of Dilong and a centipede. We have summarized in the previous clinical practice that when the original recipe of Duhuo Jisheng Decoction was modified with the above chemotherapy drugs according to the characteristics of patients’ conditions, the efficacy of the drugs could be significantly improved. At the same time, the modified application of Duhuo Jisheng Decoction can also improve the symptoms of patients according to different conditions, regulate the body’s inflammatory factors and oxidative stress with multiple targets and multiple pathways, and inhibit the degradation of extracellular matrix.In conclusion, compared with arthroscopic surgery alone, combined with modified Duhuo Jisheng Decoction therapy can better relieve the clinical symptoms of KOA patients and improve their bone metabolism, oxidative stress indexes and serum TLR4, and TGF-β1 levels, so as to reduce knee joint inflammation injury.



---

*Source: 1933504-2022-10-11.xml*